¿Is Cronos (CRON) Stock Worth Buying? скачать в хорошем качестве

¿Is Cronos (CRON) Stock Worth Buying?

Cronos loss on an Adjusted EBITDA basis — the most generous possible reading of net profit — was more than triple revenue in 2020, and only narrowly better than that in Q1. In each of the last two full years, Cronos has burned roughly $170 million. Net revenue for that period totaled just over $70 million — which almost ridiculously puts free cash flow margins near -500% over the two years. Of course, young businesses tend to burn cash as they grow. But the second fundamental issue with Cronos is that the company, while growing, simply isn't all that large. Net revenue did rise 50% year-over-year in Q1 after nearly doubling in 2020 despite the effects of the pandemic. But last year's top-line increase had some contribution from a full year of Lord Jones, the CBD (cannabidiol) manufacturer acquired in September 2019. And it shouldn't be that difficult to grow revenue when selling a product for $1 when it costs more than $2, as was the case in 2020. (Seekingalpha)